Laura Rutledge, MA, RDN, CSO is an Assistant Professor in the University of Alabama at Birmingham Department of Nutrition Sciences. She is a registered dietitian and licensed nutritionist with over 25 ...
Nogapendekin alfa inbakicept-pmln plus BCG now covers high-grade papillary-only disease, based on extrapolation from CIS ...
For MBC Awareness Day, an NP and a former ICU nurse living with metastatic breast cancer discuss repeat education, biomarker ...
Oral vitamin C at 1000 mg daily for 12 months did not slow clonal growth in adults with clonal cytopenia of undetermined ...
The University of Kansas Cancer Center The University of South Alabama, Mitchell Cancer Institute The University of Texas MD Anderson Cancer Center The Winthrop P. Rockefeller Cancer Institute at the ...
The U.S. Food and Drug Administration (FDA) approved tucatinib (Tukysa, Seagen Inc., a subsidiary of Pfizer) on October 7, ...
NP Theresa Stukus and NP Nelli Zafman discuss the practical challenges patients with metastatic triple-negative breast cancer ...
Adding atezolizumab to adjuvant FOLFOX halved the risk of recurrence or death in ATOMIC, with more grade 3 to 4 adverse events. The FDA has approved atezolizumab (Tecentriq) in combination with a ...
Following WCLC 2026, Katherine Kuhns details how perioperative immunotherapy, AI patient tools, and wearables are ...
NP Theresa Stukus and NP Nelli Zafman discuss long-term management considerations for a patient with metastatic ...
The selective internal radiation therapy SIR-Spheres has been approved by the FDA for use in patients with unresectable hepatocellular carcinoma. The FDA has approved SIR-Spheres Y-90 resin ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results